Integrated microRNA–protein plasma biomarkers improve discrimination of multiple system atrophy from Parkinson’s disease
Findings show that a non-invasive plasma multi-analyte panel can differentiate MSA from PD with clinically meaningful accuracy, and support prospective validation in larger cohorts.